Neuroacanthocytosis Syndromes: The Clinical Perspective
The two very rare neurodegenerative diseases historically known as the “neuroacanthocytosis syndromes” are due to mutations of either VPS13A or XK. These are phenotypically similar disorders that affect primarily the basal ganglia and hence result in involuntary abnormal movements as well as neurops...
Main Authors: | Ruth H. Walker, Kevin Peikert, Hans H. Jung, Andreas Hermann, Adrian Danek |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Contact |
Online Access: | https://doi.org/10.1177/25152564231210339 |
Similar Items
-
Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes
by: Ruth H. Walker
Published: (2015-05-01) -
Clinical features and molecular bases of neuroacanthocytosis.
by: Rampoldi, L, et al.
Published: (2002) -
Acanthocyte Sedimentation Rate as a Diagnostic Biomarker for Neuroacanthocytosis Syndromes: Experimental Evidence and Physical Justification
by: Alexis Darras, et al.
Published: (2021-04-01) -
McLeod neuroacanthocytosis: genotype and phenotype.
by: Danek, A, et al.
Published: (2001) -
A Case of Neuroacanthocytosis with Cerebellar Syndrome
by: Filiz Azman, et al.
Published: (2015-09-01)